Skip to main content

Table 1 Satisfaction and compliance at the end of 3-months trial of Cefaly®

From: Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study


N (%)

Satisfaction-intent to continuation



23 (65,7%)


12 (34,3%)

Completed 3 months trial



27 (81,8%)


6 (18,2%)